ANUH PHARMA
Back to Income Statement
|
ANUH PHARMA Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹662 Cr | ₹647 Cr | ₹527 Cr | ₹487 Cr | ₹432 Cr |
What is the latest Revenue of ANUH PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹662 Cr |
| Mar2024 | ₹647 Cr |
| Mar2023 | ₹527 Cr |
| Mar2022 | ₹487 Cr |
| Mar2021 | ₹432 Cr |
How is Revenue of ANUH PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹662 Cr | 2.24 | |
| Mar2024 | ₹647 Cr | 22.66 | |
| Mar2023 | ₹527 Cr | 8.39 | |
| Mar2022 | ₹487 Cr | 12.66 | |
| Mar2021 | ₹432 Cr | - | |
Compare Revenue of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹816.5 Cr | 4% | 7.9% | -23.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | 4% |
7.9% |
-23.5% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses